# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k112101   
B. Purpose for Submission: New device   
C. Measurand: Human Chorionic Gonadotropin (hCG)   
D. Type of Test: Qualitative chromatographic immunoassay   
E. Applicant: Polymed Therapeutics, Inc.   
F. Proprietary and Established Names: Fastep hCG Pregnancy Serum/Urine Cassette   
G. Regulatory Information:

<table><tr><td>Product Code</td><td>Classification</td><td>Regulation Section</td><td>Panel</td></tr><tr><td>JHI</td><td>Class II</td><td>21 CFR 862.1155, Human Chorionic Gonadotropin (HCG) test system</td><td>75 Clinical Chemistry (CH)</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications for use below

2. Indication(s) for use:

The Polymed Therapeutics Fastep™ hCG Pregnancy Serum/Urine Cassette Tests is a rapid chromatographic immunoassays for the visual, qualitative detection of human chorionic gonadotropin (hCG) in serum or urine specimen to aid in the early detection of pregnancy. For professional use only.

3. Special conditions for use statement(s):

The Polymed Therapeutics Fastep™ hCG Pregnancy Serum/Urine Cassette Test is intended for prescription use (clinical laboratory, Point of Care (POC) and physician’s office laboratory (POL) use).

The test kits are for health care professionals use including professionals at physician’s office labs (POLs) and Point-of-care sites (POC).

4. Special instrument requirements:

None, this device is a visually-read, single-use device

# I. Device Description:

The Fastep™ hCG Pegnancy Serum/Urine Test is a rapid test to detect the presence of hCG in serum or urine specimens in a qualitative format as an aid in the early detection of pregnancy. The test is available in a cassette format.

Devices are packaged one device per pouch and should be used immediately after opening.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Teco Diagnostics One-Step Urine/Serum Combo Pregnancy Test

2. Predicate 510(k) number(s): k964461

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Rapid qualitative detectionof hCG to aid in the earlydetection of pregnancy. ForPOLs settings.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen type</td><td colspan="1" rowspan="1">Urine or serum</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Test Principle</td><td colspan="1" rowspan="1">Lateral flow sandwichImmunochromatographicassay</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Detection reagent</td><td colspan="1" rowspan="1">Colloidal Gold</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Read time</td><td colspan="1" rowspan="1">Serum: 5 minutesUrine: 3 minutes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specificity</td><td colspan="1" rowspan="1">Negative at:hFSH: 1000mIU/mLhTSH: 1000 uIU/mL</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>20 mIU/ml</td><td rowspan=1 colspan=1>25 mIU/ml</td></tr><tr><td rowspan=1 colspan=1>Specificity</td><td rowspan=1 colspan=1>No effect from: hLH: 300mIU/ml</td><td rowspan=1 colspan=1>No effect from: hLH: 500mIU/ml</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Not applicable

# L. Test Principle:

The Polymed Therapeutics Fastep™ hCG Pregnancy Serum/Urine Cassette Tests is aqualitative, lateral flow sandwich immunochromatographic assay for the detection of human chorionic gonadotropin (hCG) in serum and urine. The membrane is pre-coated with monoclonal anti-hCG antibodies on the test band region and anti-mouse antibodies in the control band region. During testing, the sample reacts with the dye conjugate (mouse antihCG antibody-colloidal gold conjugate) which has been pre-coated on the test strip. The mixture them migrates upward on the membrane chromatographically by capillary action to react with anti-hCG antibodies on the membrane and generate a colored line. One colored line appears in the control region $^ { \circ } C ^ { \circ }$ regardless of the presence of hCG. The presence of this colored line in the “C” region serves as verification for sufficient volume and proper flow and as a control for the reagents. The absence of the test line in the “T” region indicates a negative result. Two colored lines should be observed in the viewing window at the “C” and “T” regions in order to indicate a positive result. No line in the $^ { \circ } C ^ { \circ }$ region will indicate that the test is invalid and needs to be repeated.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

A Point of Care (POC) study was conducted to evaluate the reproducibility of the device by the intended operators. The study was conducted at 3 healthcare POC sites by 9 healthcare professionals (HCPs) (3 operators per site). 3 different lots (one lot per site) were used for the study. The reproducibility of the device was evaluated by testing negative urine and serum samples spiked with hCG, traceable to WHO International $4 ^ { \mathrm { t h } }$ Standard, $\mathrm { \Delta ( 0 m I U / m l }$ , $1 0 \mathrm { m U / m l }$ , $1 5 \mathrm { m U / m l }$ , $2 0 \mathrm { m I U / m l }$ , $4 0 \mathrm { m I U / m l }$ and $1 0 0 \mathrm { m I U / m l } )$ ). All samples were blinded to the HCPs. Each concentration level was tested 5 times a day for 5 consecutive days. The results are summarized below:

Urine:   

<table><tr><td rowspan=2 colspan=1>hCGlevels(mIU/ml)</td><td rowspan=2 colspan=1>TotalNo.Tested</td><td rowspan=2 colspan=1>%Agreement</td><td rowspan=1 colspan=2>Site 1</td><td rowspan=1 colspan=2>Site 2</td><td rowspan=1 colspan=2>Site 3</td><td rowspan=1 colspan=2>TotalResults</td></tr><tr><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>96.9</td><td rowspan=1 colspan=1>71</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>74</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>218</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>0</td></tr></table>

Serum:   

<table><tr><td rowspan=2 colspan=1>hCGlevels(mIU/ml)</td><td rowspan=2 colspan=1>TotalNo.Tested</td><td rowspan=1 colspan=1>No.Tested</td><td rowspan=1 colspan=2>Site 1</td><td rowspan=1 colspan=2>Site 2</td><td rowspan=1 colspan=2>Site 3</td><td rowspan=1 colspan=2>TotalResults</td></tr><tr><td rowspan=1 colspan=1>per site</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(-)</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td></tr><tr><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>96.9</td><td rowspan=1 colspan=1>72</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>218</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>0</td></tr></table>

# b. Linearity/assay reportable range:

Linearity is not applicable since this is a qualitative test.

A high dose hook effect study was performed by spiking high levels of hCG concentrations 0-1,000,000 mIU/ml (0, 10, 20, 100, 62,500, 125,000, 250,000, 500,000 and 1,000,000) into negative urine and serum samples and evaluating the test result lines. A positive result was observed up to $1 , 0 0 0 , 0 0 0 \mathrm { m I U / m l }$ . Therefore no hook effect was observed for urine/serum samples with hCG concentrations up to $1 , 0 0 0 , 0 0 0 \mathrm { m I U / m l }$ .

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

The Polymed Therapeutics Fastep™ hCG Pregnancy Serum/Urine Cassette and Dipstick Test is standardized to the WHO Fourth International Standard 75/589

A shelf-life stability test of the device was performed in real-time and the results showed that the device is stable for 24 months when stored at $2 { - } 8 ^ { \circ } \mathrm { C }$ or room temperature (up to $3 0 ^ { \circ } \mathrm { C }$ ). This is a single use device and labeling states that test should be performed immediately after opening pouch.

# d. Detection limit:

The sensitivity of the device was tested by spiking pooled male urine and serum with varying concentrations (0, 10, 12.5, 15.0, 17.5, 20, 24, 30.0, 35.0, 40, and 100 $\mathrm { m U / m L }$ ) of hCG traceable to WHO International $4 ^ { \mathrm { t h } }$ Standard . Three separate lots of the device were tested in house using randomization methods. Results are summarized below.

All 3 lots combined (Urine samples):   

<table><tr><td rowspan=1 colspan=1>UrineControlshCGLevels(mIU/ml)</td><td rowspan=1 colspan=1>NumberTested</td><td rowspan=1 colspan=1>Number ofNegative</td><td rowspan=1 colspan=1>Number ofPositive</td><td rowspan=1 colspan=1>%Negative</td><td rowspan=1 colspan=1>%Positive</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>69</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>92.0</td><td rowspan=1 colspan=1>8.0</td></tr><tr><td rowspan=1 colspan=1>15.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>48.0</td><td rowspan=1 colspan=1>52.0</td></tr><tr><td rowspan=1 colspan=1>17.5</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>69</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>92.0</td></tr><tr><td rowspan=1 colspan=1>20.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>24.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>30.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>35.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>40.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>100.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

<table><tr><td rowspan=1 colspan=1>hCG Levels(mIU/ml)</td><td rowspan=1 colspan=1>NumberTested</td><td rowspan=1 colspan=1>Number ofNegative</td><td rowspan=1 colspan=1>Number ofPositive</td><td rowspan=1 colspan=1>%Negative</td><td rowspan=1 colspan=1>%Positive</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>64</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>85.3</td><td rowspan=1 colspan=1>14.7</td></tr><tr><td rowspan=1 colspan=1>15.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>49.3</td><td rowspan=1 colspan=1>50.7</td></tr><tr><td rowspan=1 colspan=1>17.5</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>68</td><td rowspan=1 colspan=1>9.3</td><td rowspan=1 colspan=1>90.7</td></tr><tr><td rowspan=1 colspan=1>20.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>24.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>30.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>35.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>40.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>100.0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

All 3 lots combined (Serum samples):

The sponsor claims a cutoff for positive as $2 0 \mathrm { m I U / m L }$ .

e. Analytical specificity:

i.) A cross-reactivity study was performed by adding known amounts of LH, FSH and TSH to pooled negative urine and serum samples. Samples were tested in duplicate. Samples were tested at 0 and $2 0 \mathrm { m I U / m l }$ of hCG. The cross-reactivity results are shown below:

Urine hCG:   

<table><tr><td rowspan=2 colspan=1>Concentration(IU/ml)</td><td rowspan=1 colspan=2>HCG 0 mIU/ml</td><td rowspan=1 colspan=2>HCG 20 mIU/ml</td></tr><tr><td rowspan=1 colspan=1>Result 1</td><td rowspan=1 colspan=1>Result 2</td><td rowspan=1 colspan=1>Result 1</td><td rowspan=1 colspan=1>Result 2</td></tr><tr><td rowspan=1 colspan=1>LH 300 mIU/mL</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(+)</td></tr><tr><td rowspan=1 colspan=1>FSH 1000 mIU/mL</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(+)</td></tr><tr><td rowspan=1 colspan=1>TSH 1000 μIU/ml</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(+)</td></tr></table>

Serum hCG   

<table><tr><td rowspan=2 colspan=1>Concentration(IU/ml)</td><td rowspan=1 colspan=2>HCG 0 mIU/ml</td><td rowspan=1 colspan=2>HCG 20 mIU/ml</td></tr><tr><td rowspan=1 colspan=1>Result 1</td><td rowspan=1 colspan=1>Result 2</td><td rowspan=1 colspan=1>Result 1</td><td rowspan=1 colspan=1>Result 2</td></tr><tr><td rowspan=1 colspan=1>LH 300 mIU/mL</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(+)</td></tr><tr><td rowspan=1 colspan=1>FSH 1000 mIU/mL</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(+)</td></tr><tr><td rowspan=1 colspan=1>TSH 1000 μIU/ml</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(-)</td><td rowspan=1 colspan=1>(+)</td><td rowspan=1 colspan=1>(+)</td></tr></table>

No cross-reactivity was observed for either urine or serum samples at the concentrations that were tested for LH, FSH and TSH.

ii.) An interference study was performed by adding known amounts of potential interfering substances to urine and serum samples that contain 0 and 20, $\mathrm { m I U / m L }$ of hCG. The sponsor states that none of the following substances at the stated concentrations interfere with the assay.

Urine Samples:   

<table><tr><td rowspan=1 colspan=1>Interfering substance</td><td rowspan=1 colspan=1>Concentration</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>2 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>EDTA</td><td rowspan=1 colspan=1>80 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>Gentensic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2 g/dl</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>1 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Methanol</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>Salicylic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr></table>

Serum Samples:   

<table><tr><td rowspan=1 colspan=1>Interfering substance</td><td rowspan=1 colspan=1>Concentration</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>2000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>40 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>EDTA</td><td rowspan=1 colspan=1>80 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>Gentensic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2 g/dl</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>125 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Methanol</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>Salicylic Acid</td><td rowspan=1 colspan=1>20 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Triglyceride</td><td rowspan=1 colspan=1>1200 mg/dl</td></tr></table>

iii.) A pH study was performed to evaluate the device and the sponsor concluded that urine and serum samples with $\mathrm { p H } 3 . 0 - 8 . 5$ would not affect the results.

iv.) A specific gravity study was performed to evaluate the device and the sponsor concluded that the performance of Fastep hCG Serum/Urine Pregnancy test at negative and cutoff points are not affected when the specific gravity range of urine specimens is at 1.00 to 1.03.

v.) Interference studies to $\beta$ -core hCG were also performed; the results indicate there was no interference with $\beta$ -core hCG up to 8.53 pmol/L

f. Assay cut-off:

See 1.d. above

2. Comparison studies:

a. Method comparison with predicate device:

A method comparison study was performed comparing the Fastep™ cassette panel to the Teco One-Step Combo Card Test (predicate device). Testing was conducted by one HCP at 4 POC sites. 19-46 individuals per site were enrolled in the study $\scriptstyle ( \mathrm { N } = 1 4 5 )$ . The samples were collected from women who fit the following categories: childbearing age, suspected pregnant women, (e.g. within days of missing the expected menses), women early in pregnancy, (e.g. within the first 30 days of pregnancy), and the first trimester of pregnancy. All samples were masked prior to analysis. Testing was performed according to the labeling.

Urine:   

<table><tr><td rowspan=5 colspan=1>Fastep™MCassette Panel</td><td rowspan=1 colspan=4>Teco One-Step Combo Card Test (predicate kit)</td></tr><tr><td rowspan=1 colspan=2>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>59</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>86</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>145</td></tr></table>

Serum:   

<table><tr><td rowspan=5 colspan=1>Fastep™MCassette Panel</td><td rowspan=1 colspan=4>Teco One-Step Combo Card Test(Predicate Kit)</td></tr><tr><td rowspan=1 colspan=2>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>58</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>87</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>86</td><td rowspan=1 colspan=1>145</td></tr></table>

b. Matrix comparison:

This test is only applicable to urine or serum samples. Performance with both of these matrices is described in the performance sections above.

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable

$b$ . Clinical specificity: Not Applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range:

The labeling states “Negative results are expected in healthy non-pregnant women” The amount of hCG will vary greatly with gestational age and between individuals.”

The telephone number of the distributor has been provided in the labeling for technical assistance.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.